Aquadeus, from Grupo Fuertes, donates €50,000 to the Spanish Federation for Rare Diseases to promote research

The company has carried out the ‘Gotas de Esperanza’ (Drops of Hope) campaign, donating €0.12 for each of the more than 400,000 packs of 12 0.5 l pink bottles of water sold

In total, Aquadeus has donated €80,000 to this NGO thanks to previous initiatives

3 March 2023. Aquadeus, a natural mineral water company belonging to Grupo Fuertes, has donated €50,000 to the Spanish Federation for Rare Diseases (FEDER [Federación Española de Enfermedades Raras]) to help them promote research into the search for diagnosis and possible treatments. In Spain, it is estimated that there are over three million people affected by some type of rare disease.

The ‘Drops of Hope’ campaign promoted by Aquadeus has the dual objective of raising funds and giving visibility to the rare disease associative movement. Specifically, Aquadeus has donated €0.12 for each of the more than 400,000 packs of 12 0.5 l pink bottles of water that have been sold.

The company has donated a total of €80,000 to this NGO thanks to previous initiatives. Aquadeus participates in a wide range of charitable work and takes part in countless events organised by NGOs and other not-for-profit organisations, with the goal of helping the collectives that need it most.

It currently collaborates nationally with the Food Bank, Cáritas and the NGO Remar. It also collaborates with associations such as Manos Unidas, UNICEF, AMAC Albacete, AMIF Villena, Astrade and the Spanish Association Against Cancer (AECC [Asociación Española Contra el Cáncer]), among others, donating over 450,000 litres in 2022 alone. The natural mineral water company Aquadeus has

two springs located in Albacete and Granada, and its waters are among the most balanced on the market due to their chemical composition.

Juan Carrión, Chairman of FEDER and its Foundation, thanked Aquadeus for giving visibility to people living with a rare disease and for its commitment to research into rare diseases, indicating that, “to date, only 20 percent of the rare diseases in existence are being researched, and this results in a long delay in diagnosis and a lack of treatment. The families living with one of these pathologies have had to wait an average of 4 years to put a name to the disease and only 34 percent of us have access to effective medicine. That is why support such as that of Aquadeus is essential for making progress and, as we at FEDER say: Research is our hope”